Finland· FI-REL-REL49333

Erlotinib STADA

A erlotinib product containing erlotinib hydrochloride, registered in Finland by STADA Arzneimittel AG. The same ATC class is registered in 14 of our 19 countries.

ATC L01EB02

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedErlotinib STADAATCL01EB02REGISTER NO.FI-REL-REL49333PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Erlotinib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EB02 (erlotinib), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose

Erlotinib · ATC L01EB02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of erlotinib costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Erlotinib · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

  • CH Switzerland$102.78
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Erlotinib hydrochloride
Manufacturer
STADA Arzneimittel AG
Country
Finland (FI)
ATC code
L01EB02
ATC class
Erlotinib
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    524088
    30
    EUR 462.35

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

355 interactions on record for erlotinib.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Erlotinib · interactions on record

355 records

  • 14 severe
  • 192 moderate
  • 2 minor
  • 147 info

Most severe, free to view

  • OmeprazoleA02BC01severe
  • PantoprazoleA02BC02severe
  • LansoprazoleA02BC03severe
  • RabeprazoleA02BC04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Erlotinib in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All erlotinib products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Belgium · Erlotinib Sandoz
  • Bulgaria · Ерлотиниб Актавис, Ерлотиниб Крка
  • Cyprus · Erlotinib Remedica
  • Czechia · Erlotinib Krka, Erlotinib Teva
  • Germany · Erlotev, Erlotinib Axiromed
  • Denmark · Erlotinib "stada", Erlotinib Krka
  • Estonia · Erlotinib Viatris
  • Spain · Erlotinib Sandoz, Erlotinib Tarbis
  • France · Erlotinib Biogaran, Erlotinib Eg
  • United Kingdom (Northern Ireland) · Erlotinib Amarox, Erlotinib Glenmark
  • Greece · Erlotinib Faran, Erlotinib Teva
  • Croatia · Erlotinib Alpha-Medical, Erlotinib Krka
  • Hungary · Erlotinib Actavis, Erlotinib Krka
  • Iceland · Erlotinib Krka, Erlotinib Teva
  • Italy · Erlotinib Mylan, Erlotinib Sandoz
  • Liechtenstein · Tarceva
  • Lithuania · Erlotinib Viatris, Varlota
  • Latvia · Erlotinib Sandoz, Erlotinib Viatris
  • Netherlands · Erlotinib Accordpharma, Erlotinib Amarox
  • Norway · Erlotinib Krka, Tarceva
  • Poland · Erlotinib Zentiva
  • Portugal · Erlotinib Mylan, Erlotinib Qritou
  • Romania · Erlotinib Krka, Erlotinib Viatris
  • Sweden · Erlotinib Krka, Erlotinib Medical Valley
  • Slovenia · Erlotinib Krka, Erlotinib Teva
  • Slovakia · Erlotinib Sandoz, Erlotinib Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d57e48c6-53fc-4faa-9e45-e65a3ac08124
GET /v1/drugs/d57e48c6-53fc-4faa-9e45-e65a3ac08124?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.15",
  "form": "tabletti, kalvopäällysteinen",
  "route": "Suun kautta",
  "ddd_unit": "g",
  "strength": "100 mg",
  "atc_label": "erlotinibi",
  "ma_number": "34301",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL49333",
  "authorised_at": "2017-08-04"
}

See everything about erlotinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.